+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Drug resistance and viral load in NUCA 3002 Lamivudine /zidovudine combination therapy versus ZDV/dideoxycytidine combination therapy in ZDV-experienced patients



Drug resistance and viral load in NUCA 3002 Lamivudine /zidovudine combination therapy versus ZDV/dideoxycytidine combination therapy in ZDV-experienced patients



INFECTIOUS DISEASES SOCIETY OF AMERICA , NATIONAL INSTITUTES OF HEALTH , CENTERS FOR DISEASE CONTROL AND PREVENTION 3rd Conference on retroviruses and opportunistic infections : 113




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031014157

Download citation: RISBibTeXText


Related references

Drug resistance and viral load in NUCA 3002 A comparative trial of lamivudine /zidovudine combination therapy vs ZDV/dideoxycytidine combination therapy in ZDV-experienced patients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(Suppl. 3): S27, 1995

A randomized, double-blind multicenter comparative trial of lamivudine /zidovudine combination therapy vs ZDV/dideoxycytidine combination therapy in ZDV experienced patients CD4 100-300mm-3. AMERICAN SOCIETY FOR MICROBIOLOGY Human retroviruses and related infections : 173, 1995

Evolution of HIV drug resistance in zidovudine/zalcitabine- and zidovudine/didanosine-experienced patients receiving lamivudine-containing combination therapy. Antiviral Therapy 3(2): 81-88, 1998

Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group. JAMA 276(2): 111-117, 1996

Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients: A randomized controlled comparison with zidovudine monotherapy. JAMA (Journal of the American Medical Association) 276(2): 111-117, 1996

Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure. Journal of Infectious Diseases 177(6): 1521-1532, 1998

Efficacy of triple combination therapy with zidovudine plus zalcitabine plus lamivudine versus double combination therapy in patients previously treated with ZDV + ddC. AIDS (London) 10(14): F61-F66, 1996

Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC. Aids 10(14): F61-F66, 1996

Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection. Aids 12(4): 439-440, 1998

Emergence of dual resistance to zidovudine and lamivudine in clinical HIV-1 isolates from patients receiving zidovudine/lamivudine combination therapy. Antiviral Therapy 3(2): 97-102, 1998

Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy. Journal of Virology 69(6): 3510-3516, 1995

Acquisition of genotypic drug resistance in zidovudine -experienced patients receiving 3TC/ZDV combination therapy or ZDV monotherapy. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(Suppl. 3): S28, 1995

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients. Aids 10(9): 975-981, 1996

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine versus zidovudine versus ZDV plus 3TC in previously untreated patients. AIDS (London) 10(9): 975-981, 1996

Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial. Antiviral Therapy 8(2): 163-171, 2003